Who owns Verrica Pharmaceuticals Inc?
- Ticker: VRCA
- CUSIP Number: 92511w207
Tip: Access positions for across all investors
Analyze quarterly positions in Verrica Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Verrica Pharmaceuticals stock
Who bought or sold Verrica Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Caligan Partners | 924k | $7.7M | 0% | Dec 2025 |
|
| Affinity Asset Advisors | 707k | $5.9M | 100% | Dec 2025 |
|
| Armistice Capital | 639k | $2.8M | 100% | Sep 2025 |
|
| Velan Capital Investment Management | 472k | $3.9M | 100% | Dec 2025 |
|
| Stonepine Capital Management | 354k | $2.9M | 100% | Dec 2025 |
|
| Boothbay Fund Management | 281k | $2.3M | 0% | Dec 2025 |
|
| DAFNA Capital Management | 174k | $1.4M | 100% | Dec 2025 |
|
| Vanguard Group | 138k | $1.1M | -39% | Dec 2025 |
|
| Jane Street | 102k | $845k | 100% | Dec 2025 |
|
| Marshall Wace | 85k | $708k | 100% | Dec 2025 |
|
| Millennium Management | 72k | $310k | 100% | Sep 2025 |
|
| Geode Capital Management | 68k | $562k | 0% | Dec 2025 |
|
| Squarepoint Ops | 33k | $277k | 100% | Dec 2025 |
|
| Sovran Advisors | 33k | $249k | -56% | Dec 2025 |
|
| Renaissance Technologies | 26k | $219k | -10% | Dec 2025 |
|
| Mariner Wealth Advisors | 25k | $204k | 0% | Dec 2025 |
|
| State Street Corporation | 24k | $195k | 14% | Dec 2025 |
|
| OMERS Administration Corporation | 23k | $188k | 100% | Dec 2025 |
|
| Northern Trust | 20k | $166k | 0% | Dec 2025 |
|
| Goldman Sachs Group | 19k | $155k | 100% | Dec 2025 |
|
| Hrt Financial | 17k | $144k | 100% | Dec 2025 |
|
| Legacy Trust | 17k | $143k | 100% | Dec 2025 |
|
| Walleye Trading Advisors | 15k | $127k | 100% | Dec 2025 |
|
| XTX Topco | 15k | $122k | 100% | Dec 2025 |
|
| Beck Mack & Oliver | 12k | $100k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 12k | $52k | 100% | Sep 2025 |
|
| Quadrature Capital | 12k | $99k | 100% | Dec 2025 |
|
| Man Group | 11k | $94k | 100% | Dec 2025 |
|
| BlackRock | 5.7k | $47k | -8% | Dec 2025 |
|
| Tower Research Capital | 3.3k | $28k | 117% | Dec 2025 |
|
| FMR | 3.3k | $14k | 100% | Sep 2025 |
|
| Capital Analysts | 1.5k | $12k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 1.2k | $5.0k | 100% | Sep 2025 |
|
| Fortitude Family Office | 608.00 | $5.1k | 100% | Dec 2025 |
|
| Salomon & Ludwin | 290.00 | $2.6k | 0% | Dec 2025 |
|
| New England Capital Financial Advisors | 200.00 | $1.7k | 0% | Dec 2025 |
|
| International Assets Investment Management | 175.00 | $1.5k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 110.00 | $914.001000 | -11% | Dec 2025 |
|
| Pnc Financial Services | 102.00 | $847.099800 | 0% | Dec 2025 |
|
| Covestor | 54.00 | $0 | 0% | Dec 2025 |
|
| Optiver Holding B.V. | 31.00 | $258.000600 | 0% | Dec 2025 |
|
| UBS Group | 24.00 | $199.000800 | -100% | Dec 2025 |
|
| Group One Trading | 3.00 | $24.999900 | 0% | Dec 2025 |
|
| MAI Wealth Advisors | 2.00 | $17.000000 | 0% | Dec 2025 |
|
| Barclays | 1.00 | $8.000000 | 0% | Dec 2025 |
|
Who sold out of Verrica Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| NISA Investment Advisors | Sep 2025 | 142.00 | $612.005800 |
| CWM | Sep 2025 | 28.00 | $0 |
| SRS Capital Advisors | Sep 2025 | 9.00 | $37.999800 |